Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Digits Replacement is a surgical intervention mainly performed to treat arthritis of the digits of the hand during which one or more damaged joint surfaces in the digits are replaced by artificial implants. GlobalData uses proprietary data and analytics to provide a comprehensive report on the digits replacement devices market, including market shares of different players within Brazil. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the digits replacement market in Brazil was DePuy Synthes followed by Smith & Nephew, KLS Martin and Stryker.
Digits Replacement covers devices (implants) used for primary replacements. Hand Digits Implants are used to replace the diseased or damaged Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) joints of the hand.
The value of the digits replacement devices market within Brazil was expected to be over $0.1m in 2023.
For the latest complete market share analysis of digits replacement device market in Brazil, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
